Long-term retention on treatment with lumiracoxib 100 mg once or twice daily compared with celecoxib 200 mg once daily: A randomised controlled trial in patients with osteoarthritis

Fleischmann, Roy; Tannenbaum, Hyman; Patel, Neha P; Notter, Marianne; Sallstig, Peter; Reginster, Jean-Yves

doi:10.1186/1471-2474-9-32

BMC Musculoskeletal Disorders

Article metrics
Last updated: Thu, 18 Apr 2024 2:24:11 Z

Long-term retention on treatment with lumiracoxib 100 mg once or twice daily compared with celecoxib 200 mg once daily: A randomised controlled trial in patients with osteoarthritis

Access & Citations

8329

Article Accesses
12

Web of Science
12

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

ISSN: 1471-2474

Contact us

Submission enquiries: bmcmusculoskeletaldisorders@biomedcentral.com
General enquiries: ORSupport@springernature.com